The purpose of this study is to create a resource that will advance research that is focused on discovery of novel therapies, risk stratification, and aggressive interventions for those at highest risk for non-alcoholic fatty liver disease (NAFLD). To achieve this, we will generate a biobank of liver tissue collected during standard of care liver biopsies. Paired blood/urine samples, FibroScan and relevant data will also be collected.
Females and Males ≥ 18 years of age.
Understands the procedures and agrees to participate by giving written informed consent.
Women who are pregnant when referred for a liver biopsy will be excluded.
Presence of any condition that, in the opinion of the Investigator, compromises participant safety or data integrity or the participant's ability to complete the study.
AdventHealth Translational Research Institute
Lead sponsor
BPGbio
Collaborator